Piramal Invests Almost $75m In Expanding Manufacturing Capacity

Company Expects Part Of Its UK Manufacturing Site To Be Functional By Next Year

Investment
Piramal expands capacity as its CDMO business grows • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business